Intrinsic Therapeutics Announces Initial Release of Its Next Generation Barricaid Narrow Anchor Device Designed to Reduce Reherniation After Back Surgery (opens in new tab)

Intrinsic Therapeutics, Inc. has introduced the Barricaid® Narrow Anchor, a new version of its FDA PMA-approved Barricaid® Bone-Anchored Annular Closure Device.